Results 231 to 240 of about 26,368 (251)

Nab-Paclitaxel plus Gemcitabin beim Pankreaskarzinom

Info Onkologie, 2014
openaire   +1 more source

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Annals of Oncology, 2015
Ralf Gutzmer
exaly  

First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis

Annals of Oncology, 2021
exaly  

nab-Paclitaxel/Gemcitabin als neue Option?

Info Onkologie, 2014
openaire   +1 more source

Weekly paclitaxel—still preferred first-line taxane for mBC

Nature Reviews Clinical Oncology, 2015
Joseph Gligorov
exaly  

nab-Paclitaxel/Gemcitabin bei metastasiertem Pankreaskarzinom

Im Focus Onkologie, 2014
openaire   +1 more source

Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial

Lancet, The
Bradley J Monk, Nicoletta Colombo, Giuseppe Caruso   +2 more
exaly  

Nab-paclitaxel/Rituximab-coated Nanoparticle AR160

2020
openaire   +1 more source

Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer

Case Medical Research, 2020
openaire   +1 more source

[FOLFIRINOX, nab-paclitaxel + gemcitabine].

Nihon rinsho. Japanese journal of clinical medicine, 2015
openaire   +1 more source